$0.86 EPS Expected for HB Fuller Co (FUL) This Quarter

Equities analysts predict that HB Fuller Co (NYSE:FUL) will report earnings per share of $0.86 for the current quarter, according to Zacks. Four analysts have made estimates for HB Fuller’s earnings. The highest EPS estimate is $0.87 and the lowest is $0.84. HB Fuller posted earnings of $0.62 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 38.7%. The business is expected to issue its next earnings results on Wednesday, June 27th.

According to Zacks, analysts expect that HB Fuller will report full-year earnings of $3.22 per share for the current financial year, with EPS estimates ranging from $3.15 to $3.30. For the next fiscal year, analysts anticipate that the company will post earnings of $4.02 per share, with EPS estimates ranging from $3.75 to $4.22. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that cover HB Fuller.

HB Fuller (NYSE:FUL) last released its quarterly earnings results on Wednesday, March 28th. The specialty chemicals company reported $0.35 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.34 by $0.01. The company had revenue of $713.08 million for the quarter, compared to the consensus estimate of $663.98 million. HB Fuller had a net margin of 3.62% and a return on equity of 11.69%.

A number of equities research analysts recently issued reports on the stock. Robert W. Baird reaffirmed a “hold” rating and set a $54.00 price target on shares of HB Fuller in a research note on Monday, April 2nd. TheStreet downgraded shares of HB Fuller from a “b” rating to a “c+” rating in a research note on Monday, February 26th. Finally, Zacks Investment Research downgraded shares of HB Fuller from a “buy” rating to a “hold” rating in a research note on Tuesday, March 20th. One analyst has rated the stock with a sell rating, five have given a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $60.50.

In other news, CFO John J. Corkrean acquired 3,200 shares of the business’s stock in a transaction on Monday, April 23rd. The shares were acquired at an average price of $51.99 per share, for a total transaction of $166,368.00. Following the completion of the transaction, the chief financial officer now directly owns 8,247 shares of the company’s stock, valued at approximately $428,761.53. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Insiders own 3.46% of the company’s stock.

Hedge funds have recently bought and sold shares of the business. Koch Industries Inc. bought a new position in HB Fuller during the fourth quarter valued at $205,000. Capital Fund Management S.A. bought a new position in HB Fuller during the fourth quarter valued at $242,000. PEAK6 Investments L.P. bought a new position in HB Fuller during the fourth quarter valued at $243,000. Xact Kapitalforvaltning AB bought a new position in HB Fuller during the fourth quarter valued at $249,000. Finally, Meadow Creek Investment Management LLC increased its position in HB Fuller by 25.1% during the fourth quarter. Meadow Creek Investment Management LLC now owns 6,972 shares of the specialty chemicals company’s stock valued at $376,000 after acquiring an additional 1,400 shares during the last quarter. Institutional investors and hedge funds own 97.68% of the company’s stock.

HB Fuller traded up $0.20, reaching $55.72, during mid-day trading on Friday, Marketbeat Ratings reports. 465,876 shares of the company’s stock traded hands, compared to its average volume of 437,630. The company has a market cap of $2.80 billion, a price-to-earnings ratio of 22.14, a PEG ratio of 1.11 and a beta of 1.54. The company has a quick ratio of 1.35, a current ratio of 2.14 and a debt-to-equity ratio of 2.08. HB Fuller has a 12-month low of $46.62 and a 12-month high of $58.74.

About HB Fuller

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, and other specialty chemical products worldwide. The company operates through six segments: Americas Adhesives; EIMEA (Europe, India, Middle East and Africa); Asia Pacific; Construction Products; Engineering Adhesives; and Royal Adhesives.

Get a free copy of the Zacks research report on HB Fuller (FUL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HB Fuller (NYSE:FUL)

Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply